GET THE APP

Harnessing Nanobots for Early Detection and Targeted Treatment of Cancer | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Harnessing Nanobots for Early Detection and Targeted Treatment of Cancer

Author(s): Ashvini Shinde*

Because they can deliver therapeutic agents efficiently and precisely, nanobots have become a promising technique in the treatment of cancer. Recent developments in the design, construction and use of nanobots in cancer treatment are highlighted in the study. Many tumours are very challenging to detect and diagnose. The management of cancer depends on the creation of novel, extremely sensitive, effective diagnostic and therapeutic techniques. The negative consequences of current therapies, such as damage from conventional chemotherapy, may be lessened if nanorobots are able to deliver and deliver large quantities of anti-cancer drugs to cancerous cells while preserving healthy cells. As nanotechnology advances, nanobots are increasingly being used in cancer detection and therapeutic treatment. By employing nanorobotic technology, the medication can be directed to a specific site, enhancing its effectiveness and minimizing the likelihood of side effects.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 15261

Der Pharma Chemica received 15261 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry